Holen Sie sich die Stockscreener-App
12.08
1.06%
-0.13
Handel nachbörslich:
11.86
-0.22
-1.82%
Schlusskurs vom Vortag:
$12.21
Offen:
$12.44
24-Stunden-Volumen:
213.50K
Relative Volume:
0.55
Marktkapitalisierung:
$403.51M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-47.68M
KGV:
-4.2837
EPS:
-2.82
Netto-Cashflow:
$-31.31M
1W Leistung:
-8.62%
1M Leistung:
-25.80%
6M Leistung:
+26.62%
1J Leistung:
+215.40%
1-Tages-Spanne:
$11.80
$12.44
1-Wochen-Bereich:
$11.11
$13.85
52-Wochen-Spanne:
$3.70
$16.97
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Vergleichen Sie DCTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
12.08 | 403.51M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Delcath Systems Reports Strong 2024 Financial Growth - TipRanks
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN
With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St
Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks
HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance UK
Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks
Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India
Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks
Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer
Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance
Delcath Systems Inc (DCTH) Q4 2024 Earnings Call Highlights: Strong HEPZATO Revenue and ... - Yahoo Finance
Delcath Systems Braces for Financial Impact Amid Uncertain Tax Law Changes - TipRanks
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN
BTIG lifts Delcath Systems stock target to $22, maintains buy By Investing.com - Investing.com Canada
BTIG lifts Delcath Systems stock target to $22, maintains buy - Investing.com
Delcath Systems reports Q4 EPS (11c), consensus 1c - TipRanks
Delcath Systems Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DELCATH SYSTEMS, INC. SEC 10-K Report - TradingView
Earnings call transcript: Delcath Systems Q4 2024 results show mixed performance - Investing.com
Delcath Systems Inc (DCTH) Q4 Earnings: Revenue Surpasses Estima - GuruFocus.com
Delcath Systems Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq
Can Delcath's 30x Revenue Growth and FDA Trial Approval Transform Cancer Treatment? - StockTitan
Delcath Systems, Inc. (NASDAQ:DCTH) Shares Acquired by Principal Financial Group Inc. - Defense World
Delcath Systems Inc. (DCTH) reports earnings - Quartz
Carcinoid Tumor Treatment Market Size in the 7MM is expected - openPR
Delcath Systems Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
(DCTH) Proactive Strategies - Stock Traders Daily
The future of U.S. medical devices companies amid tariff impositions (IHI:NYSEARCA) - Seeking Alpha
Is Corcept Therapeutics (CORT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Delcath Systems (DCTH) Expected to Announce Earnings on Thursday - Defense World
Painful week for retail investors invested in Delcath Systems, Inc. (NASDAQ:DCTH) after 14% drop, institutions also suffered losses - Simply Wall St
Where are the Opportunities in (DCTH) - Stock Traders Daily
Liver Cancer Treatment Pioneer Delcath Reports Q4 Earnings: Will Growth Continue? - StockTitan
Intrahepatic Cholangiocarcinoma Market: Analysis - openPR
Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength - Nasdaq
Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines - Marketscreener.com
Delcath Systems Announces Update to National Comprehensive Cance - WICZ
Major Treatment Breakthrough: NCCN Widens Access to Revolutionary Melanoma Therapy - StockTitan
Are You Looking for a Top Momentum Pick? Why Delcath Systems, Inc. (DCTH) is a Great Choice - MSN
Delcath Delivers 100% Gain In Less Than 6 Months - RTTNews
Analysts Say Delcath Systems Inc Can Reach $22 In 12 Months - Marketing Sentinel
Delcath Systems: Strong Position In Metastatic Uveal Melanoma, But Broader Growth Challenges Ahead - Seeking Alpha
Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 33.74%: Read This Before Placing a Bet - Nasdaq
How should investors view Delcath Systems Inc (DCTH)? - US Post News
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc. - AOL
16,978 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Baader Bank Aktiengesellschaft - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.40%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):